225 related articles for article (PubMed ID: 23936484)
1. Characterization of synthetic Chikungunya viruses based on the consensus sequence of recent E1-226V isolates.
Scholte FE; Tas A; Martina BE; Cordioli P; Narayanan K; Makino S; Snijder EJ; van Hemert MJ
PLoS One; 2013; 8(8):e71047. PubMed ID: 23936484
[TBL] [Abstract][Full Text] [Related]
2. Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection.
Ashbrook AW; Lentscher AJ; Zamora PF; Silva LA; May NA; Bauer JA; Morrison TE; Dermody TS
mBio; 2016 May; 7(3):. PubMed ID: 27222471
[TBL] [Abstract][Full Text] [Related]
3. Chikungunya virus with E1-A226V mutation causing two outbreaks in 2010, Guangdong, China.
Wu D; Zhang Y; Zhouhui Q; Kou J; Liang W; Zhang H; Monagin C; Zhang Q; Li W; Zhong H; He J; Li H; Cai S; Ke C; Lin J
Virol J; 2013 Jun; 10():174. PubMed ID: 23725047
[TBL] [Abstract][Full Text] [Related]
4. Novel Mutations in nsP2 Abolish Chikungunya Virus-Induced Transcriptional Shutoff and Make the Virus Less Cytopathic without Affecting Its Replication Rates.
Akhrymuk I; Lukash T; Frolov I; Frolova EI
J Virol; 2019 Feb; 93(4):. PubMed ID: 30487275
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral.
Delang L; Segura Guerrero N; Tas A; Quérat G; Pastorino B; Froeyen M; Dallmeier K; Jochmans D; Herdewijn P; Bello F; Snijder EJ; de Lamballerie X; Martina B; Neyts J; van Hemert MJ; Leyssen P
J Antimicrob Chemother; 2014 Oct; 69(10):2770-84. PubMed ID: 24951535
[TBL] [Abstract][Full Text] [Related]
6. Expression of plasmid-based shRNA against the E1 and nsP1 genes effectively silenced Chikungunya virus replication.
Lam S; Chen KC; Ng MM; Chu JJ
PLoS One; 2012; 7(10):e46396. PubMed ID: 23056297
[TBL] [Abstract][Full Text] [Related]
7. Construction of an infectious Chikungunya virus cDNA clone and stable insertion of mCherry reporter genes at two different sites.
Kümmerer BM; Grywna K; Gläsker S; Wieseler J; Drosten C
J Gen Virol; 2012 Sep; 93(Pt 9):1991-1995. PubMed ID: 22673932
[TBL] [Abstract][Full Text] [Related]
8. Mutation of the N-Terminal Region of Chikungunya Virus Capsid Protein: Implications for Vaccine Design.
Taylor A; Liu X; Zaid A; Goh LY; Hobson-Peters J; Hall RA; Merits A; Mahalingam S
mBio; 2017 Feb; 8(1):. PubMed ID: 28223458
[TBL] [Abstract][Full Text] [Related]
9. Anti-Chikungunya Virus Monoclonal Antibody That Inhibits Viral Fusion and Release.
Tumkosit U; Siripanyaphinyo U; Takeda N; Tsuji M; Maeda Y; Ruchusatsawat K; Shioda T; Mizushima H; Chetanachan P; Wongjaroen P; Matsuura Y; Tatsumi M; Tanaka A
J Virol; 2020 Sep; 94(19):. PubMed ID: 32699087
[TBL] [Abstract][Full Text] [Related]
10. Infectious clones of Chikungunya virus (La Réunion isolate) for vector competence studies.
Tsetsarkin K; Higgs S; McGee CE; De Lamballerie X; Charrel RN; Vanlandingham DL
Vector Borne Zoonotic Dis; 2006; 6(4):325-37. PubMed ID: 17187566
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a Chikungunya virus strain isolated from banked patients' sera.
Chalaem P; Chusri S; Fernandez S; Chotigeat W; Anguita J; Pal U; Promnares K
Virol J; 2016 Sep; 13(1):150. PubMed ID: 27590311
[TBL] [Abstract][Full Text] [Related]
12. Random codon re-encoding induces stable reduction of replicative fitness of Chikungunya virus in primate and mosquito cells.
Nougairede A; De Fabritus L; Aubry F; Gould EA; Holmes EC; de Lamballerie X
PLoS Pathog; 2013 Feb; 9(2):e1003172. PubMed ID: 23436995
[TBL] [Abstract][Full Text] [Related]
13. Tomatidine reduces Chikungunya virus progeny release by controlling viral protein expression.
Troost-Kind B; van Hemert MJ; van de Pol D; van der Ende-Metselaar H; Merits A; Borggrewe M; Rodenhuis-Zybert IA; Smit JM
PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009916. PubMed ID: 34762680
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays.
Pohjala L; Utt A; Varjak M; Lulla A; Merits A; Ahola T; Tammela P
PLoS One; 2011; 6(12):e28923. PubMed ID: 22205980
[TBL] [Abstract][Full Text] [Related]
15. Antiviral activity of silymarin against chikungunya virus.
Lani R; Hassandarvish P; Chiam CW; Moghaddam E; Chu JJ; Rausalu K; Merits A; Higgs S; Vanlandingham D; Abu Bakar S; Zandi K
Sci Rep; 2015 Jun; 5():11421. PubMed ID: 26078201
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression.
Kaur P; Thiruchelvan M; Lee RC; Chen H; Chen KC; Ng ML; Chu JJ
Antimicrob Agents Chemother; 2013 Jan; 57(1):155-67. PubMed ID: 23275491
[TBL] [Abstract][Full Text] [Related]
17. Differential Transmission of Antiviral Drug-Resistant Chikungunya Viruses by
Delang L; Yen PS; Vallet T; Vazeille M; Vignuzzi M; Failloux AB
mSphere; 2018 Aug; 3(4):. PubMed ID: 30135220
[TBL] [Abstract][Full Text] [Related]
18. Detection, isolation, and characterization of chikungunya viruses associated with the Pakistan outbreak of 2016-2017.
Liu SQ; Li X; Zhang YN; Gao AL; Deng CL; Li JH; Jehan S; Jamil N; Deng F; Wei H; Zhang B
Virol Sin; 2017 Dec; 32(6):511-519. PubMed ID: 29285673
[TBL] [Abstract][Full Text] [Related]
19. Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses.
Varghese FS; Kaukinen P; Gläsker S; Bespalov M; Hanski L; Wennerberg K; Kümmerer BM; Ahola T
Antiviral Res; 2016 Feb; 126():117-24. PubMed ID: 26752081
[TBL] [Abstract][Full Text] [Related]
20. 6'-β-Fluoro-Homoaristeromycin and 6'-Fluoro-Homoneplanocin A Are Potent Inhibitors of Chikungunya Virus Replication through Their Direct Effect on Viral Nonstructural Protein 1.
Kovacikova K; Morren BM; Tas A; Albulescu IC; van Rijswijk R; Jarhad DB; Shin YS; Jang MH; Kim G; Lee HW; Jeong LS; Snijder EJ; van Hemert MJ
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
